Peptone Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Peptone General Information

Description

Operator of a translational biophysics company intended to focus on the discovery of novel therapeutics against diseases. The company's protein engineering operating system handles a variety of mundane and complex tasks that are related to anomaly detection and risk of failure calculation and suggests the most plausible routes of failure resolution, enabling users to choose the right commercial partner to generate lab-quality molecules at a pace and cost not attainable before in the Big Pharma sector.

Contact Information

Website
www.peptone.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Connolly Works
  • 41-43 Chalton Street
  • London NW1 1JD
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Decision/Risk Analysis
Drug Discovery
Other Healthcare Technology Systems
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • The Connolly Works
  • 41-43 Chalton Street
  • London NW1 1JD
  • England, United Kingdom

Peptone Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Peptone Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 17-Jul-2023 Completed Pre-Clinical Trials
4. Later Stage VC (Series A) 09-Jun-2022 Completed Pre-Clinical Trials
3. Seed Round 08-Jan-2021 Completed Pre-Clinical Trials
2. Accelerator/Incubator 17-Apr-2018 $42.4K $42.4K Completed Pre-Clinical Trials
1. Accelerator/Incubator 19-Sep-2017 Completed Pre-Clinical Trials
To view Peptone’s complete valuation and funding history, request access »

Peptone Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
Seed Preferred 64,429 $0.000125 $32.71 $32.71 1x $32.71 15.29%
Ordinary 2,289 $0.000125 $32.71 $32.71 3x $32.71 0.54%
To view Peptone’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Peptone Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a translational biophysics company intended to focus on the discovery of novel therapeutics against diseases
Biotechnology
London, United Kingdom
40 As of 2024

Philadelphia, PA
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Peptone Competitors (11)

One of Peptone’s 11 competitors is 20n Bio, a Venture Capital-Backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
20n Bio Venture Capital-Backed Philadelphia, PA
ProteinQure Private Equity-Backed Toronto, Canada
Eikon Therapeutics Venture Capital-Backed Hayward, CA
Ingenza Venture Capital-Backed Roslin, United Kingdom
LifeMine Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 11 competitors. Get the full list »

Peptone Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Peptone Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4341936-A1 Spacio-temporal determination of polypeptide structure Pending 21-May-2021
US-20240242775-A1 Spacio-temporal determination of polypeptide structure Pending 21-May-2021
US-20240221864-A1 Spacio-temporal determination of polypeptide structure Pending 21-May-2021
US-20240194291-A1 Spacio-temporal determination of polypeptide structure Pending 21-May-2021 G16B15/30

Peptone Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Peptone Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bessemer Venture Partners Venture Capital Minority
F-Prime Capital Venture Capital Minority
Walden Catalyst Venture Capital Minority
Brent Hoberman Angel (individual) Minority
dRx Capital Novartis Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Peptone FAQs

  • When was Peptone founded?

    Peptone was founded in 2016.

  • Where is Peptone headquartered?

    Peptone is headquartered in London, United Kingdom.

  • What is the size of Peptone?

    Peptone has 40 total employees.

  • What industry is Peptone in?

    Peptone’s primary industry is Biotechnology.

  • Is Peptone a private or public company?

    Peptone is a Private company.

  • What is Peptone’s current revenue?

    The current revenue for Peptone is .

  • How much funding has Peptone raised over time?

    Peptone has raised $40.4M.

  • Who are Peptone’s investors?

    Bessemer Venture Partners, F-Prime Capital, Walden Catalyst, Brent Hoberman, and dRx Capital Novartis are 5 of 7 investors who have invested in Peptone.

  • Who are Peptone’s competitors?

    20n Bio, ProteinQure, Eikon Therapeutics, Ingenza, and LifeMine are some of the 11 competitors of Peptone.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »